Atherogenic dyslipidemia in children: Evaluation of clinical, biochemical and genetic aspects

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Montali, Anna ^a   Truglio, Gessica ^a   Martino, Francesco ^a   Ceci, Fabrizio ^a   Ferraguti, Giampiero ^a   Ciociola, Ester ^a   Maranghi, Marianna ^a   Gianfagna, Francesco ^b,c   Iacoviello, Licia ^c   Strom, Roberto ^a   Lucarelli, Marco ^a   Arca, Marcello ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Istituto di Ricerca e Cura a Carattere Scientifico Neuromed   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; INSULIN; APOA1 PROTEIN, HUMAN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID; LIPOPROTEIN LIPASE; LPL PROTEIN, HUMAN;

APOA1 GENE; ARM CIRCUMFERENCE; ARTICLE; ATHEROGENIC DYSLIPIDEMIA; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CHILD; CHILD HEALTH; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENE; GENE SEQUENCE; GENETIC TRAIT; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HERITABILITY; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LOSS OF FUNCTION MUTATION; LPL GENE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHENOTYPE; PREVALENCE; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; COMPLICATION; GENETICS; METABOLISM; MUTATION; OBESITY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOPROTEIN LIPASE; MALE; METABOLIC SYNDROME X; MUTATION; OBESITY;

EID: 84928474086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120099     Document Type: Article

References (36)

1. Krauss RM, Siri PW. Dyslipidemia in type 2 diabetes. Med Clin North Am. 2004; 88:897-909 PMID: 15308384
2. Krauss RM, Siri PW. Metabolic abnormalities: triglyceride and low-density lipoprotein. Endocrinol Metab Clin North Am. 2004; 33:405-415 PMID: 15158526
3. Grundy SM. Small LDL, atherogenic dyslipidemia and the metabolic syndrome. Circulation.1997; 95:1-4 PMID: 8994405
4. Chan DC, Watts GF. Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opin Pharmacother. 2011; 12:13-30. doi: 10.1517/14656566.2010.502529 PMID: 20629587
5. Brian W. Hyperlipidemia in children. Tromb Res. 2006; 118: 49-58 PMID: 16709475
6. Magnussen CG, Venn A, Thomson R, Juonala M, Srinivasan SR, Viikari JS, et al.The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J Am Coll Cardiol. 2009; 10: 860-869 doi: 10.1016/j.jacc.2008.09.061 PMID: 19264243
7. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem. 2006; 52: 853-859. PMID: 16556684
8. Barter P, McPherson YR, Song K, Kesäniemi YA, Mahley R, Waeber G et al. Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab. 2007; 92: 2041-5. PMID: 17389699
9. Feng Y, Zang T, Xu X, Xu X. Familial aggregation of metabolic syndrome and its components in a large Chinese population. Obesity. 2008; 16:125-129. doi: 10.1038/oby.2007.22 PMID: 18223624
10. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996; 37:693-707 PMID: 8732771
11. Kusunoki M, Tsutsumi K, Sato D, Nakamura A, Habu S, Mori Y, et al. Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats. Eur J Pharmacol. 2011; 668: 337-339 doi: 10.1016/j.ejphar.2011.06.040 PMID: 21756896
12. Miller M, Zhan M. Genetic determinants of low high-density lipoprotein cholesterol. Curr Opin Cardiol.2004; 19:380-384 PMID: 15218400
13. Campagna F, Martino F, Bifolco M, Montali A, Martino E, Morrone F et al. Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis. 2008; 196:356-364 PMID: 17196209
14. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation.2007; 115: 2316-2322 PMID: 17420347
15. Martino F, Puddu PE, Pannarale G, Colantoni C, Zanoni C, Martino E et al. Arterial blood pressure and serum lipids in a population of children and adolescents from Southern Italy: the Calabrian Sierras Community Study (CSCS). Int J Cardiol. 2013; 168:1108-1114. doi: 10.1016/j.ijcard.2012.11.045 PMID: 23201079
16. Menotti A, Seccareccia F, Lanti MD. RIFLE Project Research Group. Mean levels and distribution of some cardiovascular risk factors in Italy in the 1970's and 1980's: the Italian RIFLE Pooling Project: risk factors and life expectancy. G Ital Cardiol. 1995; 25: 1539-1572 PMID: 8707004
17. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438. PMID: 14744958
18. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004; 145:439-444 PMID: 15480363
19. Menghetti E, Virdis R, Strambi M, Patriarca V, Riccioni MA, Fossali E et al. Blood pressure in childhood and adolescence: the Italian normal standards. Study Group on Hypertension' of the Italian Society of Pediatrics. J Hypertens. 1999; 17:1363-1372 PMID: 10526895
20. Robciuc MR, Maranghi M, Lahikainen A, Rader D, Bensadoun A, Öörni K et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol. 2013; 33:1706-1713 doi: 10.1161/ATVBAHA.113.301397 PMID: 23661675
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: IR and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419. PMID: 3899825
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215. PMID: 3344216
23. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet.1998; 62:1198-1211 PMID: 9545414
24. Wägner AM, Jorba O, Rigla M, Alonso E, Ordóñez-Llanos J, Pérez A. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol. 2002; 39:215-220. PMID: 12486496
25. Fisher RM, Humphries SE, Talmud PJ. Common variations in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis.1997; 135: 145-149. PMID: 9430364
26. Reymer PW, Groenemeyer BE, Gagné E, Miao L, Appelman EE, Seidel JC et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet. 1995; 4:1543-1549 PMID: 8541837
27. De Bruin TW, Mailly F, Van Berlingen HH, Fisher R, Castro Cabezas M. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidemia. Eur J Clin Invest. 1996; 26:631-639 PMID: 8872057
28. Clivar database: Available from http://www.clinvar.com. Accessed 10 February 2014)
29. Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ et al. Lipoprotein Lipase S447X A Naturally Occurring Gain-of-Function Mutation. Arterioscler Thromb Vasc Biol.2006; 26:1236-1245 PMID: 16574898
30. Magnussen CG, Raitakari OT, Thomson R, Juonala M, Patel DA, Viikari JS et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation. 2008; 117:32-42
31. Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone.2006; 8 (Suppl 1): S21-27 PMID: 16903166
32. Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesäniemi YA, Mahley RW et al. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005; 95:194-198 PMID: 15642551
33. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006; 83:1237-1247 PMID: 16762930
34. Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD et al. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Diabetes 2003; 52:803-811. PMID: 12606523
35. Lee KE, Klein BE, Klein R. Familial aggregation of components of the multiple metabolic syndrome in the Framingham Heart and Offspring Cohorts: Genetic Analysis Workshop Problem 1. BMC Genet. 2003; 4 (Suppl 1):S94 PMID: 14975162
36. Yu Y, Wyszynski DF, Waterworth DM, Wilton SD, Barter PJ, Kesäniemi YA, et al. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res.2005; 46:2202-2213. PMID: 16061952